Glaukos (NYSE:GKOS – Free Report) had its target price boosted by Citigroup from $120.00 to $130.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the medical instruments supplier’s stock. Several other analysts have also issued reports on GKOS. JPMorgan Chase & Co. boosted their price […]